| Evaluation of MCF10A as a reliable model for normal human mammary epithelial cells Y Qu, B Han, Y Yu, W Yao, S Bose, BY Karlan, AE Giuliano, X Cui PloS one 10 (7), e0131285, 2015 | 303 | 2015 |
| Breast cancer lung metastasis: Molecular biology and therapeutic implications L Jin, B Han, E Siegel, Y Cui, A Giuliano, X Cui Cancer biology & therapy 19 (10), 858-868, 2018 | 255 | 2018 |
| FOXC1 activates smoothened-independent hedgehog signaling in basal-like breast cancer B Han, Y Qu, Y Jin, Y Yu, N Deng, K Wawrowsky, X Zhang, N Li, S Bose, ... Cell reports 13 (5), 1046-1058, 2015 | 142 | 2015 |
| FOXC1: an emerging marker and therapeutic target for cancer B Han, N Bhowmick, Y Qu, S Chung, AE Giuliano, X Cui Oncogene 36 (28), 3957-3963, 2017 | 134 | 2017 |
| FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer B Han, B Zhou, Y Qu, B Gao, Y Xu, S Chung, H Tanaka, W Yang, ... Oncogene 37 (10), 1399-1408, 2018 | 74 | 2018 |
| Differentiation of human induced pluripotent stem cells to mammary-like organoids Y Qu, B Han, B Gao, S Bose, Y Gong, K Wawrowsky, AE Giuliano, ... Stem cell reports 8 (2), 205-215, 2017 | 64 | 2017 |
| Diagnosis of basal-like breast cancer using a FOXC1-based assay TW Jensen, T Ray, J Wang, X Li, WY Naritoku, B Han, F Bellafiore, ... Journal of the National Cancer Institute 107 (8), djv148, 2015 | 58 | 2015 |
| Retinoic acid‐metabolizing enzyme cytochrome P450 26a1 (cyp26a1) is essential for implantation: functional study of its role in early pregnancy BC Han, HF Xia, J Sun, Y Yang, JP Peng Journal of cellular physiology 223 (2), 471-479, 2010 | 47 | 2010 |
| FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer Y Jin, B Han, J Chen, R Wiedemeyer, S Orsulic, S Bose, X Zhang, ... Annals of surgical oncology 21, 758-766, 2014 | 46 | 2014 |
| FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance Y Yu-Rice, Y Jin, B Han, Y Qu, J Johnson, T Watanabe, L Cheng, N Deng, ... Oncogene 35 (41), 5400-5411, 2016 | 43 | 2016 |
| Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture L Jin, Y Qu, LJ Gomez, S Chung, B Han, B Gao, Y Yue, Y Gong, X Liu, ... Oncotarget 9 (14), 11503, 2018 | 36 | 2018 |
| A novel role of IGFBP7 in mouse uterus: regulating uterine receptivity through Th1/Th2 lymphocyte balance and decidualization ZK Liu, RC Wang, BC Han, Y Yang, JP Peng Public Library of Science 7 (9), e45224, 2012 | 36 | 2012 |
| Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations SL Lim, A Damnernsawad, P Shyamsunder, WJ Chng, BC Han, L Xu, ... Haematologica 104 (6), 1209, 2019 | 35 | 2019 |
| Role of secretory protease inhibitor SPINK3 in mouse uterus during early pregnancy W Chen, BC Han, RC Wang, GF Xiong, JP Peng Cell and tissue research 341, 441-451, 2010 | 35 | 2010 |
| Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer S Chung, Y Jin, B Han, Y Qu, B Gao, AE Giuliano, X Cui Cell Communication and Signaling 15, 1-9, 2017 | 31 | 2017 |
| Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs Y Qu, B Zhou, W Yang, B Han, Y Yu-Rice, B Gao, J Johnson, ... Scientific reports 6 (1), 32007, 2016 | 25 | 2016 |
| Expression and Hormonal Regulation of Hoxa10 in Canine Uterus During the Peri‐implantation Period B Guo, Z Tian, BC Han, XM Zhang, ZM Yang, ZP Yue Reproduction in domestic animals 44 (4), 638-642, 2009 | 24 | 2009 |
| Retinoic acid synthesis and metabolism are concurrent in the mouse uterus during peri-implantation J Ma, B Han, Y Yang, J Peng Cell and tissue research 350, 525-537, 2012 | 22 | 2012 |
| FOXC1-induced Gli2 activation: A non-canonical pathway contributing to stemness and anti-Hedgehog resistance in basal-like breast cancer B Han, Y Qu, Y Yu-Rice, J Johnson, X Cui Molecular & cellular oncology 3 (3), e1131668, 2016 | 16 | 2016 |
| Basal protein expression is associated with worse outcome and trastuzamab resistance in HER2+ invasive breast cancer A Chung, M Choi, B Han, S Bose, X Zhang, L Medina-Kauwe, J Sims, ... Clinical breast cancer 15 (6), 448-457. e2, 2015 | 16 | 2015 |
